WS

William D. Shrader

EP Edison Pharmaceuticals: 7 patents #6 of 24Top 25%
PH Pharmacyclics: 7 patents #21 of 113Top 20%
BT Bioelectron Technology: 4 patents #3 of 14Top 25%
PT Ptc Therapeutics: 2 patents #88 of 160Top 60%
AP Axys Pharmaceuticals: 1 patents #51 of 111Top 50%
Overall (All Time): #193,649 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11840497 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Orion D. Jankowski, Kieron E. Wesson, Paul Mollard 2023-12-12
10968166 4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Orion D. Jankowski, Kieron E. Wesson, Paul Mollard 2021-04-06
10167251 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Orion D. Jankowski, Kieron E. Wesson, Paul Mollard 2019-01-01
9868711 Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders Andrew W. Hinman, Dana Davis 2018-01-16
9850183 Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging Mark A. Reiley, B. Michael SILBER, Julio C. Medina, Frank Kayser 2017-12-26
9670170 Resorufin derivatives for treatment of oxidative stress disorders Andrew W. Hinman, Dana Davis 2017-06-06
9629815 Benzoquinone derivatives for treating oxidative stress disorders Andrew W. Hinman, Viktoria Kheifets 2017-04-25
9546132 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Orion D. Jankowski, Kieron E. Wesson, Paul Mollard 2017-01-17
9296712 Resorufin derivatives for treatment of oxidative stress disorders Andrew W. Hinman, Dana Davis 2016-03-29
9181280 Factor VIIa inhibitor Daniel A. Dickman, Dange Vijay Kumar, Colin O'Bryan, Roopa Rai 2015-11-10
9169196 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Orion D. Jankowski, Kieron E. Wesson, Paul Mollard 2015-10-27
9162986 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors Aleksandr Kolesnikov, Roopa Rai, Steven M. Torkelson, Kieron E. Wesson, Wendy B. Young 2015-10-20
9090576 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Andrew W. Hinman, Kieron E. Wesson, Orion D. Jankowski, Edgar P. LEE 2015-07-28
8778625 2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors Aleksandr Kolesnikov, Roopa Rai, Steven M. Torkelson, Kieron E. Wesson, Wendy B. Young 2014-07-15
8729117 Factor VIIa inhibitor Daniel A. Dickman, Dange Vijay Kumar, Colin O'Bryan, Roopa Rai 2014-05-20
8716527 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Andrew W. Hinman, Kieron E. Wesson, Orion D. Jankowski, Paul Mollard, Christopher R. Cornell 2014-05-06
8519001 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Orion D. Jankowski, Kieron E. Wesson, Paul Mollard 2013-08-27
8415328 Factor VIIa inhibitor Daniel A. Dickman, Dange Vijay Kumar, Colin O'Bryan, Roopa Rai, Kieron E. Wesson 2013-04-09
8299110 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors Aleksandr Kolesnikov, Roopa Rai, Steven M. Torkelson, Kieron E. Wesson, Wendy B. Young 2012-10-30
7968746 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Orion D. Jankowski, Kieron E. Wesson, Paul Mollard 2011-06-28
7479502 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors Aleksandr Kolesnikov, Roopa Rai, Steven M. Torkelson, Kieron E. Wesson, Wendy B. Young 2009-01-20
6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors Darin Allen, Jason M. Hataye, Witold Hruzewicz, Aleksandr Kolesnikov, Richard L. Mackman +4 more 2005-03-15